Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William.

Similar presentations


Presentation on theme: "Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William."— Presentation transcript:

1 Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William Disanti, Ramona O. Rajapakse, Burton I. Korelitz, Georgia Panagopoulos, Jason Bratcher  Clinical Gastroenterology and Hepatology  Volume 4, Issue 8, Pages (August 2006) DOI: /j.cgh Copyright © 2006 American Gastroenterological Association Terms and Conditions

2 Figure 1 Rate of neoplasms after 6-MP for IBD in sustained leukopenic vs control groups. Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh ) Copyright © 2006 American Gastroenterological Association Terms and Conditions


Download ppt "Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William."

Similar presentations


Ads by Google